Insulin-like growth factor II receptor, transforming growth factor-β, and Cdk4 expression and the developmental epigenetics of mouse palate morphogenesis and dysmorphogenesis

Developmental Dynamics

Volumn 211, Issue 1, 1998, Pages 11-25

  Melnick, Michael ^a   Chen, Haiming ^a   Buckley, Susan ^b   Warburton, David ^b   Jaskoll, Tina ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Cdk4; Cleft palate; Insulin like growth factor type II receptor; Mouse genetics; Palate morphogenesis; Transforming growth factor

Indexed keywords

PLASMINOGEN ACTIVATOR; SOMATOMEDIN B RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CELL CYCLE G1 PHASE; CLEFT PALATE; CONTROLLED STUDY; CRANIOFACIAL MALFORMATION; DEVELOPMENTAL DISORDER; EMBRYO DEVELOPMENT; GENE EXPRESSION REGULATION; GENETIC SUSCEPTIBILITY; GROWTH INHIBITION; MORPHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

ANIMALS; CELL DIVISION; CLEFT PALATE; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MICE; MICE, INBRED STRAINS; MORPHOGENESIS; PALATE; PLASMINOGEN; PROTO-ONCOGENE PROTEINS; RECEPTOR, IGF TYPE 2; RNA, MESSENGER; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA; TRIAMCINOLONE ACETONIDE; URINARY PLASMINOGEN ACTIVATOR;

ANIMALIA; MAMMALIA; RODENTIA;

EID: 0031973936     PISSN: 10588388     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0177(199801)211:1<11::AID-AJA2>3.0.CO;2-A     Document Type: Article

References (83)

1. Abe M, Harpel JG, Metz CN, Koskatoff DL, Rifkin DB. An assay for transforming growth factor β using cells transfected with a plasminogen activator-1 promotor-luciferase construct. Anal. Biochem. 1994; 216:276-284.
2. Agrawal M, Brauer PR. Urokinase-type plasminogen activator regulates cranial neural crest cell migration in vitro. Dev. Dyn. 1996;207: 281-290.
3. Andrews J, McGarry JM. Acommunity study of smoking in pregnancy. J. Obstet. Gynecol. Br. Commonweal. 1972;79:1057-1073.
4. Ballard FJ, Read LC, Francis GL, Bagley CJ, Wallace JC. Binding properties and biological potencies of insulin-like growth factors in L6 myoblasts. Biochem. J. 1986;233:223-230.
5. Barcellos-Hoff MH, Derynck R, Tsang LS, Weatherbee JA. Transforming growth factor β activation in irradiated murine mammary gland. J. Clin. Invest. 1994;93:892-899.
6. Barlow DP. Gametic imprinting in mammals. Science 1995;270:1610-1613.
7. Barlow DP, Stoger R, Herrman BG, Saito K, Schweifer N. The mouse insulin-like growth factor type 2 receptor is imprinted and closely linked to the Tme locus. Nature 1991;349:84-87.
8. Barlow SM, Knight AF, Sullivan FM. Diazepam-induced cleft palate in the mouse: The role of endogenous maternal corticosterone. Teratology 1980;21:149-155.
9. Biddle FG, Fraser FC. Cortisone-induced cleft palate in the mouse. A search for the genetic control of the embryonic response trait. Genetics 1977;85:289-302.
10. Bonner JJ, Slavkin HC. Cleft palate susceptibility linked to histocompatibility-2 (H-2) in the mouse. Immunogenetics 1975;2:213-218.
11. Brunner AM, Lioubin MN, Marquardt H, Malacko AR, Wang WC, Shapiro RA, Neubauer M, Cook J, Madisen L, Purchio AF. Sitedirected mutagenesis of glycosylation sites in the transforming growth factor-β1 (TGFβ1) and TGFβ2 (414) precursors and of cysteine residues within mature TGFβ1: Effects on secretion and bioactivity. Mol. Endocrinol. 1992;6:1691-1700.
12. Carroll PM, Tsirka SE, Richards WG, Frohman MA, Strickland S. The mouse tissue plasminogen activator gene 5′ flanking region directs appropriate expression in development and a seizure-enhanced response in the CNS. Development 1994;120:3173-3183.
13. Christiansen K, Mitchell LE. Familial recurrence-pattern analysis of nonsyndromic isolated cleft palate - A Danish registry study. Am. J. Hum. Genet. 1998;58:182-190.
14. Dennis PA, Rifkin DB. Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc. Natl. Acad. Sci. USA 1991;88:580-584.
15. Derynck R. TGF-β-receptor mediated signaling. Trends Biochem. Sci. 1994;19:548-553.
16. Ellis MJC, Leav BA, Yang Z, Rasmussen A, Pearce A, Zweibel JA, Lippman ME, Cullen KJ. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells. Mol. Endocrinol. 1996;10:286-297.
17. Ferguson MWJ. Palate development. Development 1988;103:41-60.
18. Filson AJ, Louvi A, Efstratiadis A, Robertson EJ. Rescue of the T-associated maternal effect in mice carrying null mutations of Igf-2 and Igf 2r, two reciprocally imprinted genes. Development 1993;118: 731-736.
19. Fraser FC. Animal models for craniofacial disorders. In: Melnick M, Bixler D, Shields ED, eds. Etiology of Cleft Lip and Cleft Palate. New York: Alan R. Liss, Inc., 1980:1-23.
20. Fraser FC, Fainstat TD. Production of congenital defects in the offspring of pregnant mice treated with cortisone. Pediatrics 1951;8: 527-533.
21. Fraser FC, Sajoo A. Teratogenic potentials of corticosteroids in humans. Teratology 1995;51:45-46.
22. Friezner Degen SJ, Bell SM, Schaefer LA, Elliott RW. Characterization of the cDNA coding for mouse plasminogen and localization of the gene to mouse chromosome 17. Genomics 1990;8:49-61.
23. Gasser DL, Goldner-Sauve A, Katsumata M, Goldman AS. Restriction fragment length polymorphisms, glucocorticoid receptors and phenytoin-induced cleft palate in congenic strains with steroid susceptibility. J. Craniofac. Genet. Dev. Biol. 1991;11:366-371.
24. Ghosh S, Brauer PR. Latent transforming growth factor-β is present in the extracellular matrix of embryonic hearts in situ. Dev. Dyn. 1996;205:126-134.
25. Gleizes P-E, Munger JS, Nunes I, Harpel JG, Mazzieri R, Noguera I, Rifkin DB. TGF-β latency: Biological significance and mechanisms of activation. Stem Cells 1997;15:190-197.
26. Goldman AS. Biochemical mechanism of glucocorticoid- and phenytoin-induced cleft palate. In: Zimmerman EF, ed. Current Topics in Developmental Biology. New York: Academic Press, 1984:217-239.
27. Good L, Jaskoll T, Melnick M, Minkin C. The major histocompatibility complex and murine fetal development. J. Dent. Res. 1991;70:579.
28. Häckel C, Radig K, Röse I, Roessner A. The urokinase plasminogen activator (uPA) and its inhibitor (PAI-1) in embryo-fetal bone formation in the human: An immunohistochemical study. Anat. Embryol. 1995;192:363-368.
29. Haig D, Graham C. Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell 1991;64:1045-1046.
30. Hansen DK, Holson RR, Sullivan PA, Grafton TF. Alterations in maternal plasma corticosterone levels following treatment with phenytoin. Toxicol. Appl. Pharmacol. 1988;96:24-32.
31. Hanson JW, Smith DW. The fetal hydantoin syndrome. J. Pediatr. 1975;87:285-291.
32. Hu CC, Jaskoll T, Minkin C, Melnick M. The mouse major histocompatibility complex (H-2) and fetal lung development: Implications for human pulmonary maturation. Am. J. Med. Genet. 1990;35:126-131.
33. Hwang SJ, Beaty TH, Panny SR, Street NA, Joseph JM, Gordon S, Mcintosh I, Francomano CA. Association study of TGF-alpha TAQ1 polymorphism and oral clefts-indication of gene-environment interaction in population-based sample of infants with birth defects. Am. J. Epidemiol. 1995;141:629-636.
34. Jaskoll T, Hu CC, Melnick M. Mouse major histocompatibility complex and lung development: Haplotype variation, H-2 immunolocalization and progressive maturation. Am. J. Med. Genet. 1991;39:422-436.
35. Jaskoll T, Choy HA, Chen H, Melnick M. Developmental expression and CORT-regulation of TGF-β and EGF receptor mRNA during mouse palatal morphogenesis: Correlation between CORT-induced cleft palate and TGF-β2 mRNA expression. Teratology 1996a;54: 34-44.
36. Jaskoll T, Choy HA, Melnick M. The glucocorticoid-glucocorticoid receptor signal transduction pathway, transforming growth factor-β, and embryonic mouse lung development in vivo. Pediatr. Res. 1996b;39:749-759.
37. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: Biological actions. Endocrine Rev. 1995;16:3-34.
38. Keski-Oja J, Blasi F, Leof EB, Moses HL. Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-β. J. Cell Biol. 1988;106:451-459.
39. Khoury MJ, Flanders WD, Beaty TH. Penetrance in the presence of genetic susceptibility to environmental factors. Am. J. Med. Genet. 1988;29:397-403.
40. Landers ES, Botstein D. Mapping Mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 1989;121: 185-199.
41. Lau M, Stewart CEH, Liu Z, Bhatt H, Rotwein P, Stewart CL. Loss of imprinted IGF2/cation-independent mannose-6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev. 1994;8:2953-2963.
42. Lawrence DA. Transforming growth factor-β: A general review. Eur. Cytokine Netw. 1996;7:363-374.
43. Lerchner W, Barlow DP. Paternal repression of the imprinted mouse Igf 2r locus occurs during implantation and is stable in all tissues of the postimplantation mouse embryo. Mech. Dev. 1997;61:141-149.
44. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT. Molecular and cellular aspects of insulin-like growth factor I receptor. Endocrinol. Rev. 1995;16:143-163.
45. Levin SA, Grenfell B, Hastings A, Perelson AS. Mathematical and computational challenges in population biology and ecosystems science. Science 1997;275:334-343.
46. Li CC. A genetical model for emergenesis. Am. J. Hum. Genet. 1987;41:517-523.
47. Lieberman E, Torday J, Barbieri R, Cohen A, Van Vunakis H, Weiss ST. The association of in utero cigarette smoking to fetal lung maturation. Obstet. Gynecol. 1992;79:564-570.
48. Linask KK, D'Angelo M, Gehris AL, Greene RM. Transforming growth factor-β receptor profiles of human and murine embryonic palate mesenchymal cells. Exp. Cell Res. 1991;192:1-9.
49. Lyon MF, Kirby MC. Mouse chromosome atlas. In: Lyon MF, Raston S, Brown SDM, eds. Genetic Variants and Strains of the Laboratory Mouse. Oxford: Oxford University Press, 1996:881-924.
50. PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 1992;71:323-334.
51. Melnick M. Cleft lip (± cleft palate) etiology: A search for solutions. Am. J. Med. Genet. 1992;42:10-14.
52. Melnick M, Jaskoll T. H-2 haplotype and heterochronic orofacial morphogenesis in congenic mice: Consideration as a possible explanation for differential susceptibility to teratogenesis. J. Craniol. Genet. Dev. Biol. 1992;12:190-195.
53. Melnick M, Shields ED. Cleft lip and cleft palate. In: Melnick M, Shields ED, Burzynski NJ, eds. Clinical Dysmorphology of Oral-Facial Structures. Boston: John Wright-PSG, Inc., 1982:360-372.
54. Melnick M, Jaskoll T, Slavkin HC. Corticosteroid-induced cleft palate in mice and H-2 haplotype: Maternal and embryonic effects. Immunogenetics 1981a;13:443-450.
55. Melnick M, Jaskoll T, Slavkin HC. The association of H-2 haplotype with implantation, survival, and growth of murine embryos, Immunogenetics 1981b;13:303-308.
56. k in developing mouse palates using monoclonal antibody. J. Embryol. Exp. Morphol. 1982;70:45-60.
57. Melnick M, Chen H, Rich KA, Jaskoll T. Developmental expression of insulin-like growth factor II receptor in congenic mouse embryonic lungs: Correlation between IGF-IIR mRNA and protein levels and heterochronic lung development. Mol. Reprod. Dev. 1996;44:159-170.
58. Moats-Staats B, Price WA, Xu L, Jarvis HW, Stiles AD. Regulation of the insulin-like growth factor system during rat lung development. Am. J. Res. Cell. Mol. Biol. 1995;12:7035-7056.
59. Odekon LE, Blasi F, Rifkin DB. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-β to TGF-β. J. Cell. Physiol. 1994;158:398-407.
60. Palsson BO. What lies beyond bioinformatics? Nature Biotechnol. 1997:15:3-4.
61. Pelton RW, Hogan BL, Millet DA, Moses HL. Differential expression of genes encoding TGFs β1, β2, and β3 during murine palate formation. Dev. Biol. 1990;141:456-460.
62. Penrose LS. The genetical background of common diseases. Acta Genet. 1953;4:257-265.
63. Pinsky L, DiGeorge AM. Cleft palate in the mouse: A teratogenic index of glucocorticoid potency. Science 1965;147:402-403.
64. Potchinsky M, Nugent P, Lafferty C, Greene RM. Effects of dexamethsone on the expression of transforming growth-factor-beta in mouse embryonic palatal mesenchymal cells. J. Cell. Physiol. 1996;166:380-386.
65. Rasco JF, Hood RD. Maternal restraint stress-enhanced teratogenicity of all-trans-retinoic acid in CD-1-mice. Teratology 1995;51:57-62.
66. Rosenzweig S, Blaustein FM. Cleft palate in A/J mice resulting from restraint and deprivation of food and water. Teratology 1970;3: 47-52.
67. Safra MJ, Oakley GP. Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 1975;2:478-480.
68. Salomon DS, Pratt RM. Involvement of glucocorticoids in the development of the secondary palate. Differentiation 1979;13:141-154.
69. Shields ED, Bixler D, Fogh-Andersen P. Cleft palate: A genetic and epidemiologic investigation. Clin. Genet. 1981;20:13-24.
70. Sklar MM, Keiss W, Thomas CL, Nissley SP. Developmental expression of the tissue insulin-like growth factor II/mannose 6-phosphate receptor in the rat. J. Biol. Chem. 1989;264:16733-16738.
71. Smokovits A. Differences in tissue plasminogen activator activity and plasmin inhibition between newborn and adult rat. Haemostasis 1980;9:52-64.
72. Smrzka OW, Faé I, Stöger R, Kurzbauer R, Fischer GF, Henn T, Weith A, Barlow DP. Conservation of a maternal-specific methylation signal at the human IGF2R. locus. Hum. Mol. Genet. 1995;4:1945-1952.
73. Sokal RR, Rohlf FF. Biometry. San Francisco: W.H. Freeman, 1981.
74. Strohman RC. Epigenesis and complexity. The coming Kuhnian revolution in biology. Nature Biotechnol. 1997;15:194-200.
75. Szebenyi G, Rotwin P. The mouse insulin-like growth factor II/cation-independent mannose 6-phosphate (IGF-IIR/MPR) receptor gene: Molecular cloning and genomic organization. Genomics 1994;19:120-129.
76. Tanaka H, Asami O, Hayano T, Sasaki I, Yoshitake Y, Nishimura K. Identification of a family of insulin-like growth factor II secreted by cultured rat epithelial-like cell line 18,54-SF: Application of a monoclonal antibody. Endocrinology 1989;124:870-877.
77. Theiler K. The House Mouse. Atlas of Embryonic Development. New York: Springer-Verlag, 1989.
78. Vignon F, Rochefort H. Interactions of pro-cathepsin D and IGF-II on the mannose-6-phosphate/IGF-II receptor. Breast Cancer Res. Treat. 1992;22:47-57.
79. Vincek V, Sertie J, Zaleska-Rutezynska Z, Figuero F, Klein J. Characterization of H-2 congenic strains using DNA markers. Immunogenetics 1990;31:45-51.
80. Walker BE. Cleft palate produced in mice in human-equivalent dosage with triamcinolone. Science 1965;149:862-863.
81. Wang ZQ, Fund MR, Barlow DP, Wagner EF. Regulation of embryonic growth and lysosomal targeting by the imprinted Igf/Mpr gene. Nature 1994;372:464-467.
82. Xu Y, Goodyer CG, Deal C, Polychronakos C. Functional polymorphism in the parental imprinting of the human IGF2R gene. Biochem. Biophys. Res. Commun. 1993;197:747-754.
83. Zhan Y, Blanks JC, Hinton DR, Rich KA. Differing patterns of expression of insulin-like growth factor binding-proteins (IGFBPS) in the developing mouse retina. Invest. Ophthalmol. Visual Sci. 1994;35:1404a.